Faculty of Biological Sciences

Research Bulletin

Feline friends?

6th September 2012

A report showing that 350,000 people in the UK become infected with the Toxoplasma parasite each year has raised new concerns about its risks and has prompted a rethink of the dangers posed by cats.

A link between serious mental disorders, including schizophrenia, and the parasite, which is spread by cats, was observed, but studies reported in 2009 and extended in 2011 by a team from the University of Leeds' Faculty of Biological Sciences led by Dr Glenn McConkey provided key genetic evidence that the parasite Toxoplasma gondii could change production of dopamine in the brain.

Disruption of dopamine regulation is believed to be involved in a number of human psychological issues.

The work helped trigger a Food Standards Agency (FSA) review of the threat posed by Toxoplasma that reported this week and attracted wide media interest.

The FSA's Advisory Committee on the Microbiological Safety of Food (ACMSF) recommended further research into routes of Toxoplasma transmission and identification of risks of infection.

Toxoplasmosis is relatively common, with 10-20% of the UK population thought to carry the parasite as cysts. Most people with the parasite do not suffer apparent health problems. However, the impact on high risk groups including unborn children and people with immune deficiencies means that Toxoplasma ranks second among food pathogens in terms of its impact on public health.


Recent Grants

Dave Westhead and colleagues in Experimental Haematology, Cancer Research UK (Jan 2015), £700,521

Sheena Radford, Mark Harris, Peter Stockley, Alan Berry, Alex O'Neill, Thomas Edwards, Adrian Goldman, Anastasia Zhuravleva, Wellcome Trust (Jan 2015), £443,015

Bill Kunin, EU (Jan 2015), £157,490

John Colyer, Leeds Teaching Hospitals Charitable Fund (Jan 2015), £40,000

Chris Hassall, Royal Society (Dec 2014), £14,500

Ryan Seipke, Royal Society (Nov 2014), £13,700

Alan Berry, Wellcome Trust (Oct 2014), £749,865

Ian Hope, Marie-Anne Shaw, BBSRC (Oct 2014), £396,565

Alison Ashcroft, Peter Stckley, Sheena Radford, Nic Stonehouse, David Brockwell, Darren Tomlinson, BBSRC (Oct 2014), £340,937

Les Firbank, Joe Holden, BBSRC (Oct 2014), £210,302

Darren Tomlinson and colleagues in Chemistry and Pathology, anatomy and Tumour Biology, Dr Hadwen Trusy (Oct 2014), £194,475

Paul Knox, EU (Oct 2014), £167,229

Martin Stacey and colleagues in Medicine & Health, Pfizer (Oct 2014), £90,453

Darren Tomlinson and colleagues in Experimental Oncology, YCR (Oct 2014), £69,480

Andrew Macdonald, Jamel Mankouri, Kidney Research Fund UK (Oct 2014), £58,878

Mike McPherson and colleagues in Dentistry and Engineering, Wellcome Trust (Oct 2014), £58,437

Dave Westhead and colleagues in Experimental Haemotology, Leukaemia & Lymphoma Research (Sep 2014), £281,424

Emmanuel Paci and colleagues in Chemistry, BBSRC (Sep 2014), £636,759

Andrew Peel, BBSRC (Sep 2014), £371,598

Lars Jeuken, Stephen Evans, BBSRC (Sep 2014), £333,684

Lars Jeuken, BBSRC (Sep 2014), £313,463

Michelle Peckham, Mark Harris, Rao Sivaprasadarao, Eileen Ingham, Nic Stonehouse, Nikita Gamper, Wellcome Trust (Sep 2014), £192,763

Neil Ranson, BBSRC (Aug 2014), £355,253

Stuart Egginton, BHF (Aug 2014), £271,094

Darren Tomlinson, Mike McPherson, Technology Strategy Board (Aug 2014), £98,665

Peter Henderson, Leverhulme Trust (Aug 2014), £15,222

Mike McPherson (and colleagues in the School of Chemistry), EPSRC (Jul 2014), £819,880

Peter Stockley, Neil Ranson, BBSRC (Jul 2014), £455,787

Sheena Radford, Univesity of Michigan (Jul 2014), £138,452

Ryan Seipke, British Society Antimicrobial Chemistry (Jun 2014), £11,960

John Trinick, BHF (Jun 2014), £222,614

Chris West, Leverhulme Trust (Jun 2014), £181,241

Jon Lippiat, Darren Tomlinson, BBSRC (May 2014), £125,174

Christine Foyer, Royal Society (May 2014), £24,000

David Brockwell, Sheena Radford, Medimmune Ltd (Apr 2014), £337,661

Peter Stockley, Wellcome Trust (Apr 2014), £251,019

Mike McPherson, Wellcome Trust (Apr 2014), £146,596

Andrew Macdonald, Kidney Research Fund UK (Apr 2014), £127,237

Elwyn Isaac, DEFRA (Apr 2014), £126,512

Mike McPherson (and colleagues in School of Design), Technology Strategy Board (Apr 2014), £114,350

Paul Millner, Peter Stockley, Darren Tomlinson, YCR (Apr 2014), £95,874

Carrie Ferguson, Karen Birch, Shaunna Burke, Heart Research UK (Apr 2014), £60,140

Tim Benton, Technology Strategy Board (Apr 2014), £24,969

Bill Kunin, Technology Strategy Board (Apr 2014), £21,244

Dave Westhead, MRC (Apr 2014), £18,304

Recent
News

FBS Researchers volunteer to fight Ebola

17th February 2015

Four University of Leeds researchers have volunteered to fight the Ebola epidemic in Sierra Leone.


FBS Researchers discover viral code

4th February 2015

Researchers have cracked a code that governs infections by a major group of viruses including the common cold and polio.


Stroke damage mechanism identified

30th January 2015

FBS Researchers have discovered a mechanism linked to the brain damage often suffered by stroke victims—and are now searching for drugs to block it.


REF2014 success

18th December 2014

University ranked in 10th place for research and impact power in the Research Excellence Framework (REF)


Cardiovascular and Sports Exercise Research: REF success

18th December 2014

Ranked 1st in the UK for \'World Leading\' 4* research in 2014 Research Excellence Framework (REF).


International recognition for Leeds Professor

10th December 2014

Professor Anthony Turner has received a prestigious honorary doctorate from the Comenius University in Bratislava, the oldest and largest university in Slovakia.


Impact
Stories

Professor Ian Chopra and Dr Alex O'Neill have shown that high levels of FA prevent the development of resistant bacteria.

Dr Simon Goodman has investigated the disease risks to the native Galapagos fauna.

The Yorkshire Dales Environment Network is a partnership involved in the daily life and long term protection of the Yorkshire Dales.

Professors Urwin and Atkinson have developed three novel technologies for nematode control.

All impact stories